Voyager Therapeutics PE ratio VYGR

Share price divided by earnings per share over the last twelve months, since 2020.

Today, Oct 23, 2026: n/m; losses over the last year
Last meaningful: 7.3×; Mar 2025
6-year median: 5.9×
6-year range: 2.5× to 53.8×
Peer median: 14.1×

Voyager Therapeutics has no meaningful PE ratio today: it lost $1.81 a share over the last twelve months, and a PE needs earnings.

It was last meaningful in Mar 2025, at 7.3×.

On the days it had one over the last 6 years, its median was 5.9×, from 2.5× in Apr 2024 to 53.8× in Oct 2024.

PE ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2025	7.3×	7.0×	10.4×
2024	9.9×	2.5×	53.8×
2023	6.9×	2.8×	6.9×
2022	n/m a value too high to mean anything
2021	12.1×	3.0×	12.1×
2020	6.9×	6.9×	8.4×

Against its peers

Companies in Healthcare nearest Voyager Therapeutics' size, closest first, today.

Company	PE ratio
VYGRVoyager Therapeutics	n/m
KEQUKewaunee Scientific	11.9×
ICCCImmucell	128×
LFVNLifevantage	14.7×
SPROSpero Therapeutics	10.1×
PDEXPro DEX	15.1×
APTAlpha Pro Tech	13.6×
PLXProtalix BioTherapeutics	11.1×
NATRNatures Sunshine Products	12.0×
ELMDElectromed	20.1×
UTMDUtah Medical Products	22.6×
Peer median	14.1×

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on Voyager Therapeutics

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.